Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued to clients and investors on Monday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Trading Up 1.3 %

Shares of Calithera Biosciences stock opened at $0.01 on Monday. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.12. The company has a 50 day moving average of $0.01 and a 200 day moving average of $0.01.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.